MARLO WILLIAMS: Open Payments
NPI 1568168714 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $126 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $250 |
| Novo Nordisk Inc | 2 | $240 |
| Insulet Corporation | 1 | $150 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Boston Scientific Corporation | 1 | $104 |
| Gilead Sciences, Inc. | 1 | $98 |
Products named: FASENRA, Ozempic, OMNIPOD, SHINGRIX, WATCHMAN Access System.
Industry payments across WI — which companies pay providers there.
